Merger Announced

TELI Pharmaceuticals and Telomir Pharmaceuticals merger

US$47.1m consideration

NASDAQ: TELO

Advisers

Telomir Pharmaceuticals

Target

Not disclosed

Acquirer

Financial adviser
Moore
Fairness opinion
Moore
Target
Telomir Pharmaceuticals
Target based in
United States
Sector
Biotech
Tags
Biotech, Pharma

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.